Board on Global Health

Biographies

Ann E. Kurth, Ph.D., CNM, M.P.H., FAAN, (Chair), is Dean, and Linda Koch Lorimer Professor, Yale University School of . Dr. Kurth is an elected Fellow of the Institute of (National Academy of Medicine) and a member of the 2014-2018 US Preventive Services Task Force, which sets screening and primary care prevention guidelines for the United States. Dr. Kurth is 2018-2020 chair of the Consortium of Universities for Global Health. An epidemiologist and clinically-trained nurse-midwife, Dr. Kurth’s research focuses on HIV/reproductive health and global health system strengthening. Her work has been funded by the National Institutes of Health (NIAID, NIDA, NIMH, NICHD), the Bill & Melinda Gates Foundation, UNAIDS, CDC, HRSA, and others, for studies conducted in the United States and internationally. Dr. Kurth has consulted for the NIH, Gates Foundation, WHO, USAID and CDC, among others. Dr. Kurth has published over 200 peer-reviewed articles, book chapters, and scholarly monographs and presented at hundreds of scientific conferences and invited talks. Dr. Kurth has received awards for her science and leadership including the Friends of the National Institute of Nursing Research Ada Sue Hinshaw Research Award and the International Nurse Researcher Hall of Fame award from Sigma Theta Tau International.

Cheryl A. Anderson, Ph.D., M.P.H., M.S., is a Professor and Dean of the University of California San Diego Herbert Wertheim School of and Human Longevity Science. Dr. Anderson's research focuses on nutrition and chronic disease prevention in underserved populations using observational epidemiologic study designs, randomized clinical trials, and implementation science. Her research projects include the California Teachers Study; studies of stable carbon isotopes as novel dietary biomarkers for sweetened foods; clinical trials addressing lifestyle and behavioral factors for obesity reduction; and the RESOLVE to save Lives initiative. Her body of work addresses the effects of dietary patterns, sodium, and potassium intake on blood pressure and cardiovascular diseases; behavioral interventions for adherence to dietary recommendations; and identification of nutritional risk factors and for progression of kidney disease and development of cardiovascular events in individuals with chronic kidney disease. Dr. Anderson is the Director of the UC San Diego Center of Excellence in Health Promotion and Equity. She was a member of the 2015 US Dietary Guidelines Advisory Committee, and served on the National Academy of Medicine’s Food and Nutrition Board. She is the current Chair of the American Heart Association’s Epidemiology and Prevention Council and immediate past chair of the Nutrition Committee. She was elected to the National Academy of Medicine in 2016.

Ravi Anupindi, M.E., M.S., Ph.D., is Colonel William G. and Ann C. Svetlich Professor of Operations Research and Management at the Stephen M. Ross School of Business. His main research areas include technology and business innovation, global supply chain management, delivery in low and middle- income countries, economic development, and environmental & social sustainability. In his work global healthcare delivery he brings multi-disciplinary and multi-stakeholder perspectives, working collaboratively with academics from the public health and medicine, as well as practitioners in India and Africa. Specifically, in communicable diseases his work has focused on malaria and tuberculosis on issues like better costing models, models of effective resource allocations, and patient-centric service delivery models. For NCDs, his ongoing work has focused on cardiovascular disease interventions and

1

operational analysis of emergency response systems in India. He also has an interest and ongoing projects on drug shortages in the US, effectiveness of generic drugs, and challenges of scaling COVID-19 testing. He serves as a faculty expert on a task force to look into health care supply chain and national security issues. Dr. Anupindi is also co- Chair of the annual Global Health Supply Chain Summit (GHSCS) that brings together academics, country planners, NGOs, practitioners, private sector, and representatives of various multi- lateral and donor agencies to discuss the issues, progress, (new) developments in global health supply chains and delivery. Dr. Anupindi teaches classes in Global Supply Chain Management; Innovations in Global Health Delivery; and Sustainable Operations and Supply Chain Management. He is the co-author of a textbook, Managing Business Process Flows (3rd Edition), Prentice Hall, 2011. He has also authored several case studies in sustainability, healthcare delivery in low & middle income countries, and supply chain risk management. Under a USAID grant, he has assisted University of Johannesburg, South Africa develop a graduate degree program in Supply Chain Management. Dr. Anupindi is chair of (UM) President’s Advisory Committee on Labor Standards and Human Rights, was the founding Faculty Director of the Center for Value Chain Innovation (2017-2020) and the Ross Master of Supply Chain Management program (2008-2015). He is a Research Fellow at the William Davidson Institute and faculty associate with the Institute of Health Policy and Innovation, Michigan GlobalREACH, Erb Institute, Donia Center for Human Rights, Sustainable Food Systems Initiative and the Center for South Asian Studies. Dr. Anupindi is recipient the Ross School of Business Neary Teaching Excellence Award (2019), Victor L. Bernard Teaching Leadership Award (2019), and the CORE (Contribution to Research Environment) Award (2015). He was a founding board member of the People that Deliver Initiative and now serves on the board of the William Davidson Institute, the Fair Labor Association, and ProjectStanley; and as a technical advisor to Vital Ocean.

Lukoye Atwoli, MBChB, MMed Psych, Ph.D., is a Professor of and the Dean of the Aga Khan University Medical College, East Africa. He also holds a Visiting Scientist position at the Harvard T. H. Chan School of Public Health, and is an Honorary faculty at the University of Cape Town. He trained in medicine (Bachelor of Medicine and Bachelor of , MBChB) at Moi University in western Kenya, before undertaking specialist training in psychiatry ( in Psychiatry, MMed Psych) at the University of Nairobi. He later earned a Doctor of Philosophy degree from the University of Cape Town in South Africa, focusing on the epidemiology of trauma and posttraumatic stress disorder in South Africa. Dr Atwoli’s current research interests are centered on trauma and posttraumatic stress disorder and the genetics of mental disorders, although he also participates in research on children’s and youth mental health, and on HIV and Mental Health. He is working with Dr Karestan Koenen and other colleagues on the largest study on the genetics of schizophrenia and bipolar disorder in Africa, the Neuropsychiatric genetics of African populations (NeuroGAP- Psychosis) study. He is a member of the World Health Organsiation’s World Mental Health Surveys Initiative led by Ron Kessler, the largest and most prolific psychiatric epidemiology consortium in the world. Dr Atwoli chairs the Board of Directors of the Mathari National Teaching and Referral Hospital, which is the only specialised mental health facility in Kenya that serves the wider eastern africa region as well. He is also a social and health rights advocate, and has influenced policy and programmes in the health sector as well as in the political sphere in Kenya and on the African Continent. He writes a weekly column in the Sunday Nation (the largest circulation newspaper in Eastern Africa) through which he dissects social issues from a global perspective. He is the President-Elect of the African College of Neuropsychopharmacology (AfCNP), and the immediate past Vice-President of the Kenya Medical Association (KMA). He is also currently the Secretary-General of the African Association of Psychiatrists (AAP), and is an Offical Advisor to the World Medical Association’s Medical Ethics Committee

Kelly Baker, Ph.D., is an Assistant Professor in Occupational and Environmental Health, and Epidemiology at the University of Iowa’s College of Public Health, and is a faculty member of the

2

interdisciplinary Sustainable Water Development Program in the College of Engineering. Her research focuses on understanding how unsafe water, sanitation and hygiene (WASH) conditions affect maternal and child health outcomes in low and middle income countries. Her Social Microbes program uses an microbial ecology systems approach to understand the complex behavioral, environmental, and spatial- temporal mechanisms that result in young children being exposed to and infected by dozens of types of common enteric pathogens in unsanitary settings. A fundamental theory underlying this research is that in highly unsanitary settings where multiple types of enteric pathogens are dynamically transmitted between humans and animal populations over space and time, the distribution of transmission risks are characterized at the simplest level by presence and concentration of a specific pathogen and at the most complex level by simultaneous exposure to multiple types of pathogens. Dr. Baker’s group uses microbial exposure assessment and epidemiology approaches to identify and rank priority transmission pathways, as well as to evaluate the impact of WASH intervention trials. Other research in the Baker Group focuses on documenting how social and environmental barriers in meeting daily WASH needs affects women’s reproductive health, with a particular focus on the epidemiology of preterm birth and low infant birth weight outcomes in pregnant women. Dr. Baker has advised the World Bank, World Health Organization, UNICEF and several NGOs on issues related to water quality, priority enteric pathogens, and infectious disease exposure assessment and epidemiology.

Michele Barry, M.D., FACP, FASTMH, is Professor of Medicine and Tropical Diseases at Stanford University. She is the Director of the Center for Innovation in Global Health and Senior Associate Dean for Global Health. She is the founder of the Gates funded WomenLift Health initiative to put 3000 women in public and private leadership positions over ten years. As a past President of the American Society of and Hygiene (ASTMH), she led an educational initiative in tropical medicine and travelers health which culminated in diploma courses in tropical medicine both in the U.S. and overseas, as well as a U.S. certification exam. Dr. Barry is an elected member of the National Academies of Sciences, Medicine and Engineering and an elected member of The American Academy of Arts and Sciences. She has been selected for Best Doctors in America and currently sits on the NAM Board for Global Health. She is Chair of the Board of Directors for the Consortium of Universities for Global Health (CUGH) and is a recipient of the Ben Kean Medal given every three years by the ASTMH to the outstanding tropical disease educator in the U.S. She is a recipient of AMWA’s highest award – the Elizabeth Blackwell award for mentoring women in the U.S. towards careers in medicine and is the founder of the Gates funded WomenLift a global women’s leadership program in the global health private and public sectors. She has written on the impact of COVID19 on female academics amongst other areas in tropical diseases, global health and refugee health.

Chris Beyrer, M.D., M.P.H., is an infectious diseases epidemiologist and the inaugural Desmond M. Tutu Professor in Public Health and Human Rights at the Johns Hopkins Bloomberg School of Public Health in Baltimore, MD. He is Professor of Epidemiology, International Health, Health Behavior and Society, Nursing and Medicine at Johns Hopkins. He is Associate Director of the Johns Hopkins Center for Global Health (CGH), representing the Bloomberg School of Public Health in the CGH leadership. He also serves as Director of the Johns Hopkins Training Program in HIV Epidemiology and Prevention Science, as Founding Director of the Center for Public Health and Human Rights, and as Associate Director of the Johns Hopkins Center for AIDS Research (CFAR). Dr. Beyrer has extensive experience in conducting international collaborative research and training programs in Thailand, Burma/Myanmar, Laos, Malaysia, India, China, Russia, Kazakhstan, Tajikistan, Ethiopia, Malawi, Uganda, South Africa, Tanzania, Zimbabwe, Brazil, Jamaica, and the United States. He has spent much of his career focusing on HIV and other infectious diseases epidemiology, prevention science and in health and human rights. He was President of the International AIDS Society from 2014-16, and was elected to membership in the National Academy of Medicine in 2014. He currently serves as Senior Scientific Liaison to the COVID-19

3

Vaccine Prevention Network, the Co-VPN, for community engagement in the COVID-19 vaccine clinical trials.

Sarah Cleaveland. Ph.D., is a Professor of Comparative Epidemiology at the University of Glasgow, UK Institute of Biodiversity, Animal Health and Comparative Medicine. She is a veterinary epidemiologist and leads a research program investigating zoonotic and livestock diseases in Africa. Her research focuses on understanding the burden, epidemiology and control of zoonoses and has generated evidence to support the feasibility of canine rabies elimination. Professor Cleaveland is a member of the National Academy of Medicine.

Malick Diara, M.D., M.B.A., M.P.H., joined ExxonMobil in 2009 with more than 20 years of experience in international health. He is the Public Health Manager of the Exxon Mobil Corporate Medicine and Occupational Health (MOH) Department. As a member of the MOH leadership team, his responsibilities are focused on infectious disease prevention and control in ExxonMobil workplaces, and recently, on management oversight of the Company Culture of Health Program. His illustrative accomplishments include the successful establishment of the Company infectious disease outbreak management program with no operation disruption since 2010, no death due to malaria for the past 10 years with the development of a malaria drug field test that saved over 1.6 USD million within 3 years on lab costs and the launch of a global Tuberculosis control program with over 1000 TB cases averted since 2010. Prior to ExxonMobil and being based in Houston since 2009, Dr. Diara worked with private Non Profit organizations in Washington DC for 9 years and in West Africa for 12 years. With funding from USAID, the French Cooperation or the European Union, and in partnership with local authorities and organizations such as UNICEF and WHO, he supported the design, implementation and evaluation of global, national or local public health programs. Malick is a with a Medical Doctorate from Dakar School of Medicine in Senegal, a Master’s in Business Administration from the Paris School of Business – Institut Superieur de Gestion and a Masters in Public Health from Tulane University, Louisiana.

Isabel Garcia, D.D.S., M.P.H., joined the University of Florida College of as dean on Feb. 16, 2015, after retiring from the U.S. Public Health Service in 2014 as a rear admiral lower half. Garcia’s career spans 37 years in public health, clinical practice, research, teaching and administration at the local, state and national levels. Garcia joined the National Institute of Dental and Craniofacial Research at the NIH in 1995 and held multiple leadership roles during her time there. She led NIDCR’s science transfer efforts, directed the Institute’s Office of Science Policy and Analysis, and served as acting NIDCR director from 2010-2011. Garcia also served as the institute’s coordinator for global health and directed NIDCR’s Residency in Dental Public Health program from 2005 to 2014. While with the USPHS, Garcia was deployed to help prepare a major health diplomacy mission to Central and South America, which provided care to over 85,000 people in 12 countries. As deputy director of NIDCR from 2007-2014, she shared responsibility for the oversight and management of programs and functions within the institute — which included a staff of more than 400 scientists and administrators dedicated to research, training, science policy, health education, communications and financial management. Garcia received a doctorate in dental surgery in 1980 from Virginia Commonwealth University and a master’s degree in public health from the University of Michigan in 1988. She subsequently completed a residency in dental public health at the University of Michigan and a in primary care policy from the U.S. Public Health Service. A fellow of the American College of Dentists and the Pierre Fauchard Academy, Dr. Garcia is a diplomate and Past President of the American Board of Dental Public Health and an active member of the American Dental Education Association, the International Association for Dental Research, and the American Dental Association.

4

Lawrence Gostin, J.D., is University Professor (Georgetown University's highest academic rank) and the Founding Linda and Timothy O'Neill Professor of Global Health Law at Georgetown University, Professor of Public Health at Johns Hopkins University, Director of the O'Neill Institute on National and Global Law, and Director of the WHO Collaborating Center on Public Health Law and Human Rights at the Georgetown University Law Center. He is a global correspondent and contributing writer for JAMA, the journal of the American Medical Association. In 2016, President Obama appointed him to a six-year term on the National Cancer Advisory Board.

Andrew Kanter, M.D., M.P.H., FACMI, is Assistant Professor of Clinical Biomedical Informatics and Clinical Epidemiology at Columbia University. Interested in application of ICT to health in the developing world, he has worked or traveled in more than 50 countries. Prior to joining Columbia, he recently spent 12 years with a private medical informatics company where he helped develop the Healthmatics EHR now being sold by Allscripts in addition to providing medical terminology and consulting services to other electronic companies. He is currently appointed to Columbia University full-time in the Departments of Biomedical Informatics (College of & ) and Epidemiology (Mailman School of Public Health) and previously supported the development and implementation of the Millennium Villages Global-Network (MVG-Net) for the Millennium Villages Project (MVP). He directs the Columbia International eHealth Lab (CIEL) in the Department of Biomedical Informatics which supports eHealth work around the world. His work focuses on bringing real-world solutions to resource- poor settings to help them achieve the Millennium Development Goals.

Karestan Koenen, Ph.D., does research and teaches about trauma and posttraumatic stress disorder (PTSD). The broad goal of her work is three-fold. First, she studies why, when exposed so a similar traumatic event, some persons develop PTSD while others are resilient. She is particularly interested in how genes shape risk for PTSD. Much of this work is done through the PTSD working group of the Psychiatric Genomics Consortium that she co-leads with Kerry Ressler and Israel Liberzon. Second, she investigates how trauma and PTSD influence weight gain and alter long-term physical health including chronic diseases such as cardiovascular disease and type-2-diabetes. Third, she documents global burden of trauma and PTSD through her work with the World Mental Health Surveys. Dr. Koenen also advocates for victims of sexual violence. In May 2011, Dr. Koenen testified before the House Foreign Affairs Full Committee about the epidemic of sexual violence and victim blaming culture of the Peace Corps. She has written for the Boston Globe, the Washington Post, the Huffington Post, and the Women’s Media Center’s Women Under Siege Project, a journalism project founded by Gloria Steinem that investigates how rape and other forms of sexualized violence are used as tools in conflict. Dr. Koenen also consulted with award-winning documentary filmmaker Lisa Jackson on the film It Happened Here, which investigates the epidemic of sexual assault on university campuses. Dr. Koenen currently lives in Boston. When not working, she is likely taking a yoga class or spending time with her son, Lorcan.

Orin Levine, Ph.D., leads the foundation’s efforts to accelerate the introduction of new vaccines and related technologies and to improve routine immunization systems. He is the Foundation’s focal point for engagement with the GAVI Alliance whose mission is saving children’s lives by increasing access to immunization in poor countries. Before joining the foundation’s Global Development Program in 2012, Dr. Levine was a Professor of International Health, and Executive Director of the International Vaccine Access Center (IVAC) at the Johns Hopkins University’s Bloomberg School of Public Health. He has also served as a Steering Committee Member of the Decade of Vaccines Collaboration and Co-Chair of its Global Access Working Group, as well as President, Committee on Global Health, American Society of Tropical Medicine & Hygiene. Dr. Levine graduated with a Bachelor’s degree from Gettysburg College and received a PhD in epidemiology from The Johns Hopkins Bloomberg School of Public Health.

5

Maureen Lichtveld, M.D., M.P.H., is dean of the Graduate School of Public Health, where she oversees the growth and continued success of the school’s seven academic departments and hundreds of students, faculty, and staff. She also serves as professor of environmental and occupational health and is the Jonas Salk Professor of Population Health. Dr. Lichtveld studies environmental public health, focusing on environmentally induced disease, health disparities, environmental health policy, disaster preparedness, public health systems, and community resilience. Her research examines the cumulative impact of chemical and non-chemical stressors on communities facing environmental health threats, disasters, and health disparities. Before joining Pitt in January 2021, Dr. Lichtveld chaired Tulane University’s Department of Environmental Health Sciences in the School of Public Health and Tropical Medicine. She also directed the Center for Gulf Coast Environmental Health Research, Leadership, and Strategic Initiatives within Tulane’s public health and tropical medicine school. In this role, Dr. Lichtveld led development and implementation of disaster management, health promotion, and disease- prevention strategies for Gulf Coast communities. Prior to her arrival at Tulane in 2005, Dr. Lichtveld spent 18 years with the U.S. Centers for Disease Control and Prevention and the U.S. Department of Health and Human Services Agency for Toxic Substances and Disease Registry, where she designed public health research tools and protocols to guide environmental health studies in communities located near hazardous waste sites. Dr. Lichtveld is a member of the National Academy of Medicine and a member of the board of the Consortium of Universities for Global Health. She received her M.P.H. from Johns Hopkins University’s School of Hygiene and Public Health and her M.D. from Anton de Kom University of Suriname and the University of Leiden in the Netherlands.

John C. Martin, Ph.D., M.B.A., joined Gilead Sciences in 1990 and was Executive Chairman from March 2016 through March 2019. He served as Chairman and Chief Executive Officer from June 2008 through March 2016 and President and Chief Executive Officer from 1996 through May 2008. Prior to joining Gilead, John held several leadership positions at Bristol-Myers Squibb and Syntex Corporation. John currently serves on the Board of Directors at the Scripps Research Institute, Kronos Bio, and Sarepta Therapeutics. John previously served as President of the International Society for Antiviral Research, Chairman of the Board of Directors of BayBio and Chairman of the Board of Directors of the California Healthcare Institute (CHI). He served on the National Institute of & Infectious Diseases Council, the Board of Directors of the Biotechnology Industry Organization, the Board of Directors for CHI, the Board of Trustees of the University of Chicago, the Board of Trustees of Golden Gate University and the External Scientific Advisory Board of the University of California School of Global Health. Additionally, John served on the Centers for Disease Control/Health Resources and Services Administration’s Advisory Committee on HIV and STD Prevention and Treatment and was a member of the Presidential Advisory Council on HIV/AIDS. John holds a Ph.D. in organic chemistry from the University of Chicago, an MBA from Golden Gate University and his B.S. degree in chemical engineering from Purdue University. He has received the Isbell Award from the American Chemical Society, the Gertrude B. Elion Award for Scientific Excellence from the International Society for Antiviral Research, and the NAS Award for Chemistry in Service to Society. In 2008, John was inducted into the National Academy of Engineering of the National Academies.

Gbenga Ogedegbe, M.D., M.P.H., M.S., a physician, is the Adolph & Margaret Berger Professor of Population Health & Medicine, Chief Division of Health & Behavior and Director Center for Healthful Behavior Change in the Department of Population Health at New York University School of Medicine. Gbenga is a leading expert on health disparities research; his work focuses on the implementation of evidence-based interventions for cardiovascular risk reduction in minority populations. He is Principal Investigator on numerous NIH projects, and has expanded his work globally to Sub-Saharan Africa where he is funded by the NIH to strengthen research capacity and reduce the burden of noncommunicable

6

diseases. He has co-authored over 250 publications and his work has been recognized by receipt of several research and mentoring awards including the prestigious John M. Eisenberg Excellence in Mentorship Award from the Agency for Healthcare Research and Quality, and the Daniel Savage Science Award. He has served on numerous scientific panels including the NIH, CDC, World Health Organization, and the European Union Research Council. Prior to joining NYU, he was faculty at Cornell Weill and Columbia University College of Physicians and Surgeons.

Dorothy Peprah, Ph.D., M.P.H., is a Senior Global Health Security Agenda Advisor at USAID with over 15 years of global health experience focused on social and behavioral change interventions, vaccination, community-based prevention and response to infectious disease outbreaks and emerging infectious diseases, and health systems strengthening in contexts of political transition and fragile states. She has worked with a variety of international organizations (e.g., the International Rescue Committee, BBC Media Action, and World Health Organization) and academic institutions to deliver programs and conduct research to improve health outcomes in various communities in collaboration with local stakeholders and governments officials. Her experience spans the range of humanitarian and development settings including Sierra Leone, South Sudan, Ghana, Ethiopia, Afghanistan and other countries for health promotion, women’s empowerment, and the advancement of global health security. She has been recognized for her leadership in global health security by the USAID Mission in Guinea and Sierra Leone. She is a board member of the Institute of Women and Ethnic Studies (IWES) that allows her to address public health consequences of structural inequities in the United States. Dr. Peprah received her Masters in Public Health from Boston University’s School of Public Health and her doctorate from the London School of Hygiene and Tropical Medicine.

Scott C. Ratzan, M.D., M.P.A., M.A., is engaged in advancing multisector engagement for sustainable health. He currently is developing Health Communication for Social Change efforts at the City University of New York (CUNY) Graduate School of Public Health & Health Policy as well as leading the development of Business Partners for Sustainable Development with the U.S. Council for International Business Foundation. He also serves as Editor-in-Chief of the Journal of Health Communication: International Perspectives. He From 2018-19, he was Senior Fellow at Mossavar-Rahmani Center for Business & Government at Harvard Kennedy School, where he developed Guiding Principles for Multisector Engagement and a series of articles on vaccine acceptance. He was founding President of the Anhueser-Busch (AB) InBev Foundation, and now serves as a Director. He had eleven years of experience in Vice President roles at Johnson & Johnson, at headquarters and in Brussels. Before his private sector engagement, he worked at the U.S. Agency for International Development (USAID) in Washington, D.C., and in academia as a professor and Founding Director of the Emerson-Tufts Master’s Program in Health Communication. He currently serves on the Board of Global Health for the National Academies of Science, Engineering and Medicine, Rand Health Advisory Board, and Massachusetts General Hospital Board of Global Health and has previously been on the Board of Scientific Counselors for the Centers for Disease Control and Prevention, Office of Infectious Disease. Dr. Ratzan received his M.D. from the University of Southern California, an M.P.A. from Harvard Kennedy School, and an M.A. from Emerson College. His academic appointments include Adjunct Professor at Columbia University Mailman School of Public Health, Tufts University School of Medicine, and George Washington University.

Carlos del Rio, M.D., is a Distinguished Professor of Medicine in the Division of Infectious Diseases at Emory University School of Medicine and Executive Associate Dean for Emory at Grady. He is also Professor of Global Health in the Department of Global Health and Professor of Epidemiology at the Rollins School of Public Health. He is also co-Director of the Emory Center for AIDS Research (CFAR) and co-PI of the Emory-CDC HIV Clinical Trials Unit and the Emory Vaccine and Treatment Evalaution Unit.

7

Dr. del Rio is a native of Mexico where he attended medical school at Universidad La Salle, graduating in 1983. He did his and Infectious Diseases residencies at Emory University. In 1989 he returned to Mexico where he was Executive Director of the National AIDS Council of Mexico (CONASIDA, the Federal agency of the Mexican Government responsible for AIDS Policy throughout Mexico), from 1992 through 1996. In November of 1996 he returned to Emory where he has been involved in patient care, teaching and research. Dr. del Rio was Chief of the Emory Medical Service at Grady Memorial Hospital from 2001 - 2009 and Chair of the Department of Global Health from 2009 - 2019. Dr. del Rio’s research focuses on the early diagnosis, access to care, engagement in care, compliance with antiretrovirals and the prevention of HIV . He has worked for over a decade with hard-to-reach populations including substance users to improve outcomes of those infected with HIV and to prevent infection with those at risk. He is also interested in the translation of research findings into practice and policy. His international work includes collaborations in the country of Georgia, Ethiopia, Vietnam, Mexico, Kenya and Thailand. He has also worked on emerging such as pandemic influenza and was a member of the WHO Influenza A(H1N1) Clinical Advisory Group and of the CDC Influenza A(H1N1) Task Force during the 2009 pandemic. Dr. del Rio is a Member of the Board of Directors of the International Antiviral Society-USA (IAS-USA) and was a Board member and Chair of HIVMA of the Infectious Diseases Society of America (IDSA). He is a also the Chair of the PEPFAR Scientific Advisory Board. He is Chief Section Editor for HIV/AIDS for NEJM Journal Watch Infectious Diseases, Associate Editor for Clinical Infectious Diseases and member of the editorial board of Journal of AIDS and Global Public Health. Dr. del Rio has co-authored 30 book chapters and over 350 scientific papers. Among his many honors are the James H. Nakano Citation received in 2001 and awarded by the CDC for an outstanding scientific paper published in 2000; the Emory University Marion V. Creekmore Achievement Award for Internationalization; he was selected by the “Atlanta Magazine” as one of the 55 most influential foreign born Atlantans in 2007. In 2013 Dr. del Rio was elected to the National Academy of Medicine and in 2020 was elected as Foreign Secretary of the National Academy of Medicine.

Kathleen H. Sienko, S.M., Ph.D., is an Arthur F. Thurnau Professor in the Department of Mechanical Engineering at the University of Michigan. She founded and directs the University of Michigan Global Health Design Initiative, and co-founded the University of Michgian Center for Socially Engaged Design. Areas of scholarly interest include medical device design, task shifting/sharing medical devices, design science, rehabiliation engineering, and engineering education. Her research leverages quantitative and qualitative methods to support design ethnography field work, benchtop/pre-clinical trials, usability testing, and clinical trials to explore human-device interactions and inform the design and development of medical devices, with a special emphasis on socially- and contextually-centered design of technologies for global health applications. She has served as a member of the WHO Advisory Group on Innovative Technologies, and contributed to the WHO Global Forums on Medical Devices and the development of WHO Compendia of Innovative Technologies that compile information about technologies designed for use in low- and middle-income countries.

Sarah Tishkoff, Ph.D., M.Phil., is the David and Lyn Silfen University Professor in Genetics and Biology at the University of Pennsylvania, holding appointments in the School of Medicine and the School of Arts and Sciences. Dr. Tishkoff studies genomic and phenotypic variation in ethnically diverse Africans. Her research combines field work, laboratory research, and computational methods to examine African population history and how genetic variation can affect a wide range of practical issues – for example, why humans have different susceptibility to disease, how they metabolize drugs, and how they adapt through evolution. Dr. Tishkoff is a member of the National Academy of Sciences and a recipient of an NIH Pioneer Award, a David and Lucile Packard Career Award, a Burroughs/Wellcome Fund Career Award, and a Penn Integrates Knowledge (PIK) endowed chair. She is a member of the board of directors of the American Society of Human Genetics and is on the editorial boards at PLOS Genetics, Genome

8

Research; Evolution, Medicine, and Public Health; G3 (Genes, Genomes, and Genetics). Her research is supported by grants from the National Institutes of Health and the National Science Foundation.

9